The "Key" to COVID-19 Vaccine Development Lies in the Way the Virus Binds to Human Cells
Read Time: New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead, and a biomedical scientist at Iowa State University believes the âkeyâ to that development lies in the way the virus binds to human cells. Michael Cho, a professor of biomedical sciences at Iowa State, is studying how to develop COVID-19 vaccines that target SARS-CoV-2âs receptor-binding domain, or the part of the virus that docks with the host cellular receptor, angiotensin converting enzyme 2 (ACE2). This docking process allows the virus...
Source: technologynetworks.com